Both experimental and clinical research indicate that RAS inhibitors—especially ARBs, as well as ACE inhibitors and renin inhibitors—play a role in RA by primarily targeting inflammation and oxidative stress [247]. The gene discussed is ACE; the disease is rheumatoid arthritis.